Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Seminars in Oncology is Scopus-indexed (Q2, CiteScore 4.9), WoS SCIE. Published by W.B. Saunders.
Checked against the index lists dated .
ISSN 0093-7754Verify ISSN ↗1532-8708Verify ISSN ↗
Publisher: W.B. Saunders
Cost to publish: About US$3,550 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Hematology | 40 / 151 | 73rd | Q2 |
| Oncology | 160 / 428 | 62nd | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1974–present, best quartile Q2, CiteScore 4.9.
Seminars in Oncology is Q2 in Hematology (rank 40 of 151) and Q2 in Oncology (rank 160 of 428), by CiteScore 2025.
Seminars in Oncology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.9, which places it in quartile Q2 at the 73rd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.536, quartile Q1, with an H-index of 153.
The publisher lists an article processing charge of about US$3,550 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Seminars in Oncology is published by W.B. Saunders. Its print ISSN is 0093-7754 and its online ISSN is 1532-8708.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Seminars in Oncology has an h-index of 149 and a 2-year mean of 2.76 citations per paper (OpenAlex). Its Scopus CiteScore is 4.9, quartile Q2. On 2-year citations it ranks #31 of 148 Scopus journals in Hematology.
Seminars in Oncology published 96 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2025–2026), authors are most often from China (30.9%), India (13.9%) and United States (9.3%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.